Investor Presentaiton

Profitable growth trends All values in Rs Cr. GROSS MARGIN EBITDA 26% 9,228 25% 8,540 24% 24% 26.6% ** 23% 7,580 60% 4,134 6,058 3,617 3,625 5,331 58% 57% 2,541 2,782 3,318 55% 52% FY12 FY13 FY14 Gross Margin FREE CASH FLOWS FY15 -% to Sales FY16 FY12 FY13 FY14 FY15 FY16 EBITDA Adj. EBITDA % to Sales 876 930 695 589 ROCE 26.8%** 1,875 29.6% 28.3% 28.2% 26.1% 22.4% FY12 FY13 FY14 FY15 FY16 ■Free Cash Flow Investor Presentation - 2016 FY12 FY13 FY14 FY15 FY16 ROCE ...... Adj. ROCE ** **Adjusting for the Venezuela related accrual taken in FY 16 Dr. Reddy's Laboratories Ltd. 17

View entire presentation